UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Paraelectric properties of PLT(28) reactively sputtered by multi-element metal target

Proceedings of 1994 IEEE International Symposium on Applications of Ferroelectrics, 1994, p.472-475

1994

Volltextzugriff (PDF)

Indentation damage zone in calcium and lead titanate ceramics

British ceramic transactions, 1999-06, Vol.98 (6), p.296-298

1999

Volltextzugriff (PDF)

Deformation and fracture behavior of an 8090 Al-Li alloy at cryogenic temperature

Scripta metallurgica et materialia, 1995-04, Vol.32 (8), p.1255-1260

1995

Volltextzugriff (PDF)

A negative impedance converter using an in-line cryotron

Proceedings of the IEEE, 1968-01, Vol.56 (2), p.205-205

1968

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

The New England journal of medicine, 2020-02, Vol.382 (7), p.610-621

2020

Volltextzugriff (PDF)

SiO2 microparticles with carbon nanotube-derived mesopores as an efficient support for enzyme immobilization

Chemical engineering journal (Lausanne, Switzerland : 1996), 2019-03, Vol.359, p.1252-1264

2019

Volltextzugriff (PDF)

Clonorchis sinensis omega-class glutathione transferases are reliable biomarkers for serodiagnosis of clonorchiasis and opisthorchiasis

Clinical microbiology and infection, 2019-01, Vol.25 (1), p.109.e1-109.e6

2019

Volltextzugriff (PDF)

SnO2 hollow nanotubes: a novel and efficient support matrix for enzyme immobilization

Scientific reports, 2017-11, Vol.7 (1), p.1-11, Article 15333

2017

Volltextzugriff (PDF)

Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial

Stroke (1970), 2020-03, Vol.51 (3), p.931-937

2020

Volltextzugriff (PDF)

A pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111)

Annals of oncology, 2018-11, Vol.29, p.ix5-ix5

2018

Volltextzugriff (PDF)

176P Poziotinib for HER2-positive metastatic breast cancer (MBC): Final clinical efficacy and safety results for long-term follow-up of the phase II NOV120101-203 trial

Annals of oncology, 2022-05, Vol.33, p.S207-S208

2022

Volltextzugriff (PDF)

Characterization of a silkworm thioredoxin peroxidase that is induced by external temperature stimulus and viral infection

Insect biochemistry and molecular biology, 2005, Vol.35 (1), p.73-84

2005

Volltextzugriff (PDF)

432P Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician’s choice in HER2-low, hormone receptor–positive metastatic breast cancer in DESTINY-Breast04

Annals of oncology, 2024-09, Vol.35, p.S401-S402

2024

Volltextzugriff (PDF)

Catalytic properties of a lipase from Photobacterium lipolyticum for biodiesel production containing a high methanol concentration

Journal of bioscience and bioengineering, 2009-06, Vol.107 (6), p.599-604

2009

Volltextzugriff (PDF)

274TiP Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01

Annals of oncology, 2022-09, Vol.33, p.S663

2022

Volltextzugriff (PDF)

Substituents engineered deep-red to near-infrared phosphorescence from tris-heteroleptic iridium( iii ) complexes for solution processable red-NIR organic light-emitting diodes

Journal of materials chemistry. C, Materials for optical and electronic devices, 2018, Vol.6 (39), p.10640-10658

2018

Volltextzugriff (PDF)

Estimated long-term dietary exposure to lead, cadmium, and mercury in young Korean children

European journal of clinical nutrition, 2014-12, Vol.68 (12), p.1322-1326

2014

Volltextzugriff (PDF)

Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial

Lancet neurology, 2018-06, Vol.17 (6), p.509-518

2018

Volltextzugriff (PDF)

Comparison the effect on fasting blood sugar between atorvastatin and pitavastatin in korean population

Atherosclerosis, 2015-07, Vol.241 (1), p.e196-e196

2015

Volltextzugriff (PDF)

124P Phase Ib-II neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive stage II/III breast cancer (Neo-PATH) (KCSG BR 18-23, NCT03991878)

Annals of oncology, 2021-09, Vol.32, p.S412-S412

2021

Volltextzugriff (PDF)

Comparison and correlation analysis of different Swine breeds meat quality

Animal Bioscience, 2013, 26(7), , pp.905-910

2013

Volltextzugriff (PDF)

103P Long-term results and bone-protective effect of everolimus added to letrozole and ovarian function suppression for premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated analysis of the LEO study

Annals of oncology, 2021-05, Vol.32, p.S67

2021

Volltextzugriff (PDF)

311PD - Leuprorelin (LEUP) combined with Letrozole (LET) with/without everolimus (EVE) in ovarian suppressed premenopausal women with hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC): Primary analysis of LEO Trial (NCT02344550)

Annals of oncology, 2019-10, Vol.30, p.v107-v107

2019

Volltextzugriff (PDF)

Leuprorelin (LEUP) combined with Letrozole (LET) with/without everolimus (EVE) in ovarian suppressed premenopausal women with hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC): Primary analysis of LEO Trial (NCT02344550)

Annals of oncology, 2019-10, Vol.30, p.v107

2019

Volltextzugriff (PDF)

47MO Efficacy and quality of life (QOL) in premenopausal Asian patients (pts) with hormone receptor–positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) treated in the MONALEESA (ML)-7 study

Annals of oncology, 2020-11, Vol.31, p.S1260-S1260

2020

Volltextzugriff (PDF)

26 – 50 von 158

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(152)

Publikationsform

Artikel
(150)
Tagungsberichte
(8)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(48)
Animals
(31)
Female
(19)
Technology
(18)
Humans
(17)
Male
(17)
Physical Sciences
(15)
Exact Sciences And Technology
(14)
Physics
(13)
Parasitology
(12)
Biochemistry & Molecular Biology
(11)
Biological And Medical Sciences
(11)
Materials Science
(10)
Molecular Sequence Data
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)
Adult
(8)
Applied Sciences
(8)
Engineering
(8)
Phylogeny
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Paraelectric properties of PLT(28) reactively sputtered by multi-element metal target

Indentation damage zone in calcium and lead titanate ceramics

Deformation and fracture behavior of an 8090 Al-Li alloy at cryogenic temperature

A negative impedance converter using an in-line cryotron

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer

SiO2 microparticles with carbon nanotube-derived mesopores as an efficient support for enzyme immobilization

Clonorchis sinensis omega-class glutathione transferases are reliable biomarkers for serodiagnosis of clonorchiasis and opisthorchiasis

SnO2 hollow nanotubes: a novel and efficient support matrix for enzyme immobilization

Cilostazol Versus Aspirin in Ischemic Stroke Patients With High-Risk Cerebral Hemorrhage: Subgroup Analysis of the PICASSO Trial

A pilot study of single pegfilgrastim compared with intermittent every other days of 5 shot-filgrastim in breast cancer patients receiving adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy (G-CSF 105 trial: NCT02685111)

176P Poziotinib for HER2-positive metastatic breast cancer (MBC): Final clinical efficacy and safety results for long-term follow-up of the phase II NOV120101-203 trial

Characterization of a silkworm thioredoxin peroxidase that is induced by external temperature stimulus and viral infection

432P Exploratory biomarker analysis of trastuzumab deruxtecan versus treatment of physician’s choice in HER2-low, hormone receptor–positive metastatic breast cancer in DESTINY-Breast04

Catalytic properties of a lipase from Photobacterium lipolyticum for biodiesel production containing a high methanol concentration

274TiP Datopotamab deruxtecan (Dato-DXd), a TROP2 antibody-drug conjugate, vs investigators’ choice of chemotherapy (ICC) in previously-treated, inoperable or metastatic hormone-receptor (HR) positive, HER2-negative (HR+/HER2–) breast cancer: TROPION-Breast01

Substituents engineered deep-red to near-infrared phosphorescence from tris-heteroleptic iridium( iii ) complexes for solution processable red-NIR organic light-emitting diodes

Estimated long-term dietary exposure to lead, cadmium, and mercury in young Korean children

Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial

Comparison the effect on fasting blood sugar between atorvastatin and pitavastatin in korean population

124P Phase Ib-II neoadjuvant chemotherapy with docetaxel plus atezolizumab plus herceptin SC and pertuzumab (TAHP) for patients with HER2-positive stage II/III breast cancer (Neo-PATH) (KCSG BR 18-23, NCT03991878)

Comparison and correlation analysis of different Swine breeds meat quality

103P Long-term results and bone-protective effect of everolimus added to letrozole and ovarian function suppression for premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer: An updated analysis of the LEO study

311PD - Leuprorelin (LEUP) combined with Letrozole (LET) with/without everolimus (EVE) in ovarian suppressed premenopausal women with hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC): Primary analysis of LEO Trial (NCT02344550)

Leuprorelin (LEUP) combined with Letrozole (LET) with/without everolimus (EVE) in ovarian suppressed premenopausal women with hormone receptor (HR) positive, HER2-negative metastatic breast cancer (MBC): Primary analysis of LEO Trial (NCT02344550)

47MO Efficacy and quality of life (QOL) in premenopausal Asian patients (pts) with hormone receptor–positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC) treated in the MONALEESA (ML)-7 study

Suchergebnisse filtern